PLUS1
142.75
0.26 (0.18%)
0.26 (0.18%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | JNJ | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.78 | -0.54% | 142.49 | 140.58 | 144.425 | 142.76 | 143.27 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 65,791 | 5,738,566 | $ 142.61 | $ 818,394,629 | 7,586,135 | 109.16 - 157.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:56:06 | 5 | $ 142.75 | USD |
Johnson and Johnson Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 375.65B | 2.64B | 2.63B | $ 82.06B | $ 15.22B | 5.63 | 21.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 13.76M | $ 3.75 | 2.63% | - | - |
Johnson and Johnson News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/02/2020 | 08:37 | Dow Jones News | European Union Approves Janssen Ebola Vaccine |
| 7/02/2020 | 06:00 | Dow Jones News | Merck KGaA, Janssen to Develop Automated Diagnostic Tool for.. |
| 7/01/2020 | 10:23 | Dow Jones News | Johnson & Johnson Unit Gets European OK for Preventive Ebola.. |
| 7/01/2020 | 09:11 | Dow Jones News | Minerva Neurosciences Opts Out of Agreement With Janssen for.. |
| 6/18/2020 | 16:37 | Edgar (US Regulatory) | Annual Report of Employee Stock Plans (11-k) |
| 6/18/2020 | 16:34 | Edgar (US Regulatory) | Annual Report of Employee Stock Plans (11-k) |
| 6/11/2020 | 16:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 141.25 | 144.425 | 140.33 | 142.57 | 5,740,372 | 1.24 | 0.88% |
| 1 Month | 148.78 | 149.17 | 137.02 | 141.68 | 7,385,314 | -6.29 | -4.23% |
| 3 Months | 148.31 | 157.00 | 137.02 | 146.94 | 7,862,134 | -5.82 | -3.92% |
| 6 Months | 145.08 | 157.00 | 109.16 | 140.80 | 9,527,558 | -2.59 | -1.79% |
| 1 Year | 141.46 | 157.00 | 109.16 | 137.54 | 8,370,667 | 1.03 | 0.73% |
| 3 Years | 132.74 | 157.00 | 109.16 | 135.74 | 7,031,046 | 9.75 | 7.35% |
| 5 Years | 99.05 | 157.00 | 81.79 | 126.43 | 6,766,367 | 43.44 | 43.86% |
Johnson and Johnson Description
| Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States. |
